Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis.
Frontiers in Psychiatry 2024 Alexandros Matsingos, Marcel Wilhelm, Laila Noor et al. 18 citations
Ketamine and esketamine offer a novel approach in the pharmacological treatment of major depressive disorder (MDD). This meta-analysis aimed to investigate the placebo response in double-blind, randomized controlled studies (RCTs) on patients with MDD receiving ketamine or esketamine. For this systematic review and meta-analysis Medline (PubMed), Cochrane Central Register of Controlled Trials...